Kim S Betts1, Fairlie McIlwraith2, Paul Dietze3, Elizabeth Whittaker4, Lucy Burns5, Shelley Cogger6, Rosa Alati7. 1. The University of Queensland, Australia. Electronic address: kim.betts@uqconnect.edu.au. 2. QADREC, Level 3, School of Population Health Building, University of Queensland, Brisbane, Australia. Electronic address: f.mcilwraith@sph.uq.edu.au. 3. MacFarlane Burnet Institute for Medical and Public Health Research, Melbourne, Australia. Electronic address: pauld@burnet.edu.au. 4. National Drug and Alcohol Centre, University of New South Wales, NSW 2052, Australia. Electronic address: e.whittaker@unsw.edu.au. 5. National Drug and Alcohol Centre, University of New South Wales, NSW 2052, Australia. Electronic address: l.burns@unsw.edu.au. 6. MacFarlane Burnet Institute for Medical and Public Health Research, Melbourne, Australia. Electronic address: shelley@burnet.edu.au. 7. School of Public Health and Centre for Youth Substance Abuse Research, University of Queensland, Brisbane, Australia. Electronic address: r.alati@sph.uq.edu.au.
Abstract
BACKGROUND: This study investigates whether the type, nature or amount of polysubstance use can explain the increased risk of non-fatal overdose among people who inject drugs with severe psychological distress. METHODS: Data came from three years (2011-2013) of the Illicit Drug Reporting System (IDRS), an annual sentinel sample of injecting drug users across Australia (n=2673). Structural Equation Modelling (SEM) was used on 14 drug types to construct five latent factors, each representing a type of polysubstance use. Tests of measurement invariance were carried out to determine if polysubstance use profiles differed between those with and without severe psychological distress. Next, we regressed non-fatal overdose on the polysubstance use factors with differences in the relationships tested between groups. FINDINGS: Among those with severe psychological distress a polysubstance use profile characterised by heroin, oxycodone, crystal methamphetamine and cocaine use was associated with greater risk of non-fatal overdose. Among those without severe psychological distress, two polysubstance use profiles, largely characterised by opioid substitution therapies and prescription drugs, were protective against non-fatal overdose. CONCLUSION: The types of polysubstance use profiles did not differ between people who inject drugs with and without severe psychological distress. However, the nature of use of one particular polysubstance profile placed the former group at a strongly increased risk of non-fatal overdose, while the nature of polysubstance use involving opioid substitution therapies was protective only among the latter group. The findings identify polysubstance use profiles of importance to drug-related harms among individuals with psychological problems.
BACKGROUND: This study investigates whether the type, nature or amount of polysubstance use can explain the increased risk of non-fatal overdose among people who inject drugs with severe psychological distress. METHODS: Data came from three years (2011-2013) of the Illicit Drug Reporting System (IDRS), an annual sentinel sample of injecting drug users across Australia (n=2673). Structural Equation Modelling (SEM) was used on 14 drug types to construct five latent factors, each representing a type of polysubstance use. Tests of measurement invariance were carried out to determine if polysubstance use profiles differed between those with and without severe psychological distress. Next, we regressed non-fatal overdose on the polysubstance use factors with differences in the relationships tested between groups. FINDINGS: Among those with severe psychological distress a polysubstance use profile characterised by heroin, oxycodone, crystal methamphetamine and cocaine use was associated with greater risk of non-fatal overdose. Among those without severe psychological distress, two polysubstance use profiles, largely characterised by opioid substitution therapies and prescription drugs, were protective against non-fatal overdose. CONCLUSION: The types of polysubstance use profiles did not differ between people who inject drugs with and without severe psychological distress. However, the nature of use of one particular polysubstance profile placed the former group at a strongly increased risk of non-fatal overdose, while the nature of polysubstance use involving opioid substitution therapies was protective only among the latter group. The findings identify polysubstance use profiles of importance to drug-related harms among individuals with psychological problems.
Authors: Gerald Cochran; Jennifer L Bacci; Thomas Ylioja; Valerie Hruschak; Sharon Miller; Amy L Seybert; Ralph Tarter Journal: J Am Pharm Assoc (2003) Date: 2016-03-24
Authors: Rachel E Gicquelais; Mary Jannausch; Amy S B Bohnert; Laura Thomas; Srijan Sen; Anne C Fernandez Journal: Drug Alcohol Depend Date: 2020-05-16 Impact factor: 4.492
Authors: Noa Krawczyk; Matthew Eisenberg; Kristin E Schneider; Tom M Richards; B Casey Lyons; Kate Jackson; Lindsey Ferris; Jonathan P Weiner; Brendan Saloner Journal: Ann Emerg Med Date: 2019-09-09 Impact factor: 5.721
Authors: James J Mahoney; Erin L Winstanley; Laura R Lander; James H Berry; Patrick J Marshalek; Marc W Haut; Jennifer L Marton; Wesley D Kimble; Matthew Armistead; Sijin Wen; Yilin Cai; Sally L Hodder Journal: Addict Behav Date: 2020-12-04 Impact factor: 3.913
Authors: Alexis M Roth; John Rossi; Jesse L Goldshear; Quan Truong; Richard F Armenta; Stephen E Lankenau; Richard S Garfein; Janie Simmons Journal: Subst Use Misuse Date: 2017-02-08 Impact factor: 2.362
Authors: Rachael M Lyons; Amy M Yule; Davida Schiff; Sarah M Bagley; Timothy E Wilens Journal: J Child Adolesc Psychopharmacol Date: 2019-06-27 Impact factor: 3.031